Bio Pappel, S.A.B. de C.V.:企業の戦略・SWOT・財務情報

◆英語タイトル:Bio Pappel, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5805
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bio Pappel, S.A.B. de C.V. – Strategy, SWOT and Corporate Finance Report
Summary

Bio Pappel, S.A.B. de C.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bio Pappel, S.A.B. de C.V. (Bio Pappel) is a company which is involved in manufacture of paper and related products. It primarily involves in the manufacturing of variety of paper and related products from recycled paper. The company’s product portfolio includes writing and printing paper including bond paper and newsprint. The company also manufactures sustainable corrugated cardboards, paper sacks, high-performance paper and light-weight paper for packaging, and paper for paper bags. The company caters the needs of manufacturers of durable and consumer goods in Mexico, Latin America and the US, including major exporters in Mexico. Bio Pappel is headquartered in Durango, Mexico.

Scope

- Detailed information on Bio Pappel, S.A.B. de C.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bio Pappel, S.A.B. de C.V. in the form of a SWOT analysis
- An in-depth view of the business model of Bio Pappel, S.A.B. de C.V. including a breakdown and examination of key business segments
- Intelligence on Bio Pappel, S.A.B. de C.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bio Pappel, S.A.B. de C.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bio Pappel, S.A.B. de C.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bio Pappel, S.A.B. de C.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bio Pappel, S.A.B. de C.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Bio Pappel, S.A.B. de C.V.: Company Overview 6
Bio Pappel, S.A.B. de C.V.: Overview and Key Facts 6
Bio Pappel, S.A.B. de C.V.: Overview 6
Bio Pappel, S.A.B. de C.V.: Key Facts 6
Bio Pappel, S.A.B. de C.V.: Key Employees 8
Bio Pappel, S.A.B. de C.V.: Key Employee Biographies 9
Bio Pappel, S.A.B. de C.V.: Major Products and Services 10
Bio Pappel, S.A.B. de C.V.: Company History 11
Bio Pappel, S.A.B. de C.V.: Locations and Subsidiaries 12
Bio Pappel, S.A.B. de C.V.: Key Competitors 13
Bio Pappel, S.A.B. de C.V.: Company Analysis 14
Bio Pappel, S.A.B. de C.V.: Business Description 14
Bio Pappel, S.A.B. de C.V.: SWOT Analysis 15
Bio Pappel, S.A.B. de C.V.: SWOT Overview 15
Bio Pappel, S.A.B. de C.V.: Strengths 15
Bio Pappel, S.A.B. de C.V.: Weaknesses 16
Bio Pappel, S.A.B. de C.V.: Opportunities 16
Bio Pappel, S.A.B. de C.V.: Threats 17
Bio Pappel, S.A.B. de C.V.: Recent Developments 18
Bio Pappel, S.A.B. de C.V.: News and Events Summary 18
Bio Pappel, S.A.B. de C.V.: IT Spending Announcements 18
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Bio Pappel, S.A.B. de C.V.: Key Facts
Table 2: Bio Pappel, S.A.B. de C.V.: Key Employees
Table 3: Bio Pappel, S.A.B. de C.V.: Company History
Table 4: Bio Pappel, S.A.B. de C.V.: Locations and Subsidiaries
Table 5: Bio Pappel, S.A.B. de C.V.: Key Competitors
Table 6: Bio Pappel, S.A.B. de C.V.: News and Events Summary
Table 7: Bio Pappel, S.A.B. de C.V.: IT Spending Announcements



★海外企業調査レポート[Bio Pappel, S.A.B. de C.V.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daihatsu Motor Co Ltd:企業の戦略・SWOT・財務情報
    Daihatsu Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daihatsu Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • National Rural Utilities Cooperative Finance Corporation:企業の戦略・SWOT・財務情報
    National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report Summary National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • Implenia AG:戦略・SWOT・企業財務分析
    Implenia AG - Strategy, SWOT and Corporate Finance Report Summary Implenia AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fremont Michigan InsuraCorp Inc.:企業の戦略・SWOT・財務情報
    Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析
    AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • Apexigen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company t hat focuses on discovery and development of antibody-based drugs for the treatment of cancer.The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell r …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • FitLife Brands Inc:企業の戦略・SWOT・財務情報
    FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, a an inactivated hepatitis A vaccine; bilive, a combined inactivated hepatitis A and B vaccine; anflu, a split viron influenz …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • Antibe Therapeutics Inc (ATE):医療機器:M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Enbridge Energy Partners LP (EEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Enbridge Energy Partners LP (EEP) is a midstream energy partnership that owns and operates a diversified portfolio of crude oil and liquids transportation systems in the US. It provides services through interstate pipeline transportation and storage of crude oil and liquid petroleum. The par …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • First Bancorp. (FBP):企業の財務・戦略的SWOT分析
    First Bancorp. (FBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆